• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR MITRACLIP G4 CLIP DELIVERY SYSTEM; MITRAL VALVE REPAIR DEVICES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR MITRACLIP G4 CLIP DELIVERY SYSTEM; MITRAL VALVE REPAIR DEVICES Back to Search Results
Model Number N/A
Device Problem Unintended Movement (3026)
Patient Problems Cardiogenic Shock (2262); Syncope/Fainting (4411); Heart Failure/Congestive Heart Failure (4446); Mitral Valve Insufficiency/ Regurgitation (4451)
Event Date 03/07/2022
Event Type  Death  
Manufacturer Narrative
The clip remains in patient.The device will not be returned for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
This is filed to report a patient death.It was reported that the patient underwent a mitraclip procedure on (b)(6) 2021 to treat functional mitral regurgitation (mr) with a grade of 4.One clip was successfully implanted, reducing the final mr to a grade of 2.On (b)(6) 2022, the patient was admitted to the hospital due to syncope.A right heart catheterization was performed and x-ray revealed that the implanted clip opened.No damage was noted, and the clip remained stable and attached to both leaflets.The patient¿s mr grade was rated severe and the patient had a low ejection fraction (ef).The patient died on (b)(6) 2022 due to severe heart failure and cardiogenic shock.The physician stated that the patient¿s symptoms and heart failure were related to the increased mr.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar complaints reported from this lot.The recurrent mitral regurgitation (mr) appears to be related to the reported clip open while locked.The syncope, shock, heart failure and subsequent death appear to be related to the recurrent mr.The reported hospitalization was a result of case-specific circumstance.Mr, syncope, shock, heart failure and death are listed in the instructions for use (ifu) as known possible complications associated with mitraclip procedures.The investigation determined the reported clip open while locked appears to be related to a potential quality product issue.The issue is being addressed per internal operating procedures.Abbott will continue to trend the performance of these devices.This event was further reviewed by an abbott global medical affairs director and the reviewer stated ¿in this case of grade 4 functional mitral regurgitation, the patient underwent a mitraclip procedure on (b)(6) 2021.One clip was successfully implanted, reducing the final mr to a grade of 2.On (b)(6) 2022, the patient was hospitalized due to syncope.X-ray revealed that the implanted clip opened.No damage was noted, and the clip remained stable and attached to both leaflets.The patient¿s mr grade was rated severe.Patient had a low ejection fraction (ef) and was medically treated.The patient died sometime between (b)(6) 2022 and (b)(6) 2022 due to severe heart failure and cardiogenic shock.The physician stated that the patient¿s symptoms and heart failure were related to the increased mr.There is no evidence that death was related to the device but increased mr post-procedure likely triggered a cascading effect on worsening heart failure leading to death.¿ this event was further reviewed by a clinical staff engineer research & development, and the reviewer stated that ¿one (1) fluoroscopic video and one (1) fluoro still image was provided at the following denoted time points: (b)(6) 2021 (procedure date) and (b)(6) 2022 (follow up date).In total, four (4) fluoroscopic cine were provided.The (b)(6).2021 fluoro shows the fully deployed clip which appears to be fully closed (~10°) per the instructions for use.The (b)(6) 2022 fluoro shows the same clip but with apparent opening of the clip arms, as compared to the state of the clip (fully closed ~10°) post procedure in (b)(6) 2021.Based on a visual examination with the naked eye, the clip arm angle in the follow up fluoro from (b)(6) 2022 appears to be ~60°.However, this is only a best approximation and cannot be confirmed.Based on the fluoro cine provided, it is evident that the clip arms opened an unconfirmed amount as compared to post procedure in (b)(6) 2021.¿.
 
Event Description
N/a.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP G4 CLIP DELIVERY SYSTEM
Type of Device
MITRAL VALVE REPAIR DEVICES
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key13951646
MDR Text Key288212001
Report Number2024168-2022-03336
Device Sequence Number1
Product Code NKM
UDI-Device Identifier08717648231001
UDI-Public08717648231001
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/07/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/25/2022
Device Model NumberN/A
Device Catalogue NumberCDS0701-XTW
Device Lot Number10525R149
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/08/2022
Initial Date FDA Received03/30/2022
Supplement Dates Manufacturer Received05/17/2022
Supplement Dates FDA Received06/07/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/26/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age73 YR
Patient SexFemale
-
-